The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pancreatic Cancer Diagnostic-Global Market Insights and Sales Trends 2025
Synopsis
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and the term "pancreatic cancer" is sometimes used to refer only to that type. These adenocarcinomas start within the part of the pancreas that makes digestive enzymes. Several other types of cancer, which collectively represent the majority of the no adenocarcinomas, can also arise from these cells. About 1-2% of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma.
The global Pancreatic Cancer Diagnostic market size is expected to reach US$ 9411.2 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Pancreatic Cancer Diagnostic in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Pancreatic Cancer Diagnostic market. Imaging, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tumor Biomarker segment is estimated at % CAGR for the next seven-year period.
Global Pancreatic Cancer Diagnostic main manufactuers include Siemens, GE Healthcare, Roche, Philips Healthcare, totally accounting for 15% of the market. North America is the largest market, with a share about 40%. As for the types of products, it can be divided into imaging, tumor biomarker, biopsy and others. The most common type is imaging, with a share over 63%. As for the types of applications, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share over 45%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pancreatic Cancer Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pancreatic Cancer Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pancreatic Cancer Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pancreatic Cancer Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pancreatic Cancer Diagnostic covered in this report include Siemens, GE Healthcare, Roche, Philips Healthcare, Danaher, Canon Medical Systems, Abbott, Hitachi Medical and Qiagen, etc.
The global Pancreatic Cancer Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens
GE Healthcare
Roche
Philips Healthcare
Danaher
Canon Medical Systems
Abbott
Hitachi Medical
Qiagen
Myriad Genetics
Global Pancreatic Cancer Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pancreatic Cancer Diagnostic market, Segment by Type:
Imaging
Tumor Biomarker
Biopsy
Others
Global Pancreatic Cancer Diagnostic market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pancreatic Cancer Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and the term "pancreatic cancer" is sometimes used to refer only to that type. These adenocarcinomas start within the part of the pancreas that makes digestive enzymes. Several other types of cancer, which collectively represent the majority of the no adenocarcinomas, can also arise from these cells. About 1-2% of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma.
The global Pancreatic Cancer Diagnostic market size is expected to reach US$ 9411.2 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Pancreatic Cancer Diagnostic in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Pancreatic Cancer Diagnostic market. Imaging, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tumor Biomarker segment is estimated at % CAGR for the next seven-year period.
Global Pancreatic Cancer Diagnostic main manufactuers include Siemens, GE Healthcare, Roche, Philips Healthcare, totally accounting for 15% of the market. North America is the largest market, with a share about 40%. As for the types of products, it can be divided into imaging, tumor biomarker, biopsy and others. The most common type is imaging, with a share over 63%. As for the types of applications, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share over 45%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pancreatic Cancer Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pancreatic Cancer Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pancreatic Cancer Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pancreatic Cancer Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pancreatic Cancer Diagnostic covered in this report include Siemens, GE Healthcare, Roche, Philips Healthcare, Danaher, Canon Medical Systems, Abbott, Hitachi Medical and Qiagen, etc.
The global Pancreatic Cancer Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens
GE Healthcare
Roche
Philips Healthcare
Danaher
Canon Medical Systems
Abbott
Hitachi Medical
Qiagen
Myriad Genetics
Global Pancreatic Cancer Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pancreatic Cancer Diagnostic market, Segment by Type:
Imaging
Tumor Biomarker
Biopsy
Others
Global Pancreatic Cancer Diagnostic market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pancreatic Cancer Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pancreatic Cancer Diagnostic
1.1 Pancreatic Cancer Diagnostic Market Overview
1.1.1 Pancreatic Cancer Diagnostic Product Scope
1.1.2 Pancreatic Cancer Diagnostic Market Status and Outlook
1.2 Global Pancreatic Cancer Diagnostic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pancreatic Cancer Diagnostic Market Size by Region (2018-2029)
1.4 Global Pancreatic Cancer Diagnostic Historic Market Size by Region (2018-2023)
1.5 Global Pancreatic Cancer Diagnostic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pancreatic Cancer Diagnostic Market Size (2018-2029)
1.6.1 North America Pancreatic Cancer Diagnostic Market Size (2018-2029)
1.6.2 Europe Pancreatic Cancer Diagnostic Market Size (2018-2029)
1.6.3 Asia-Pacific Pancreatic Cancer Diagnostic Market Size (2018-2029)
1.6.4 Latin America Pancreatic Cancer Diagnostic Market Size (2018-2029)
1.6.5 Middle East & Africa Pancreatic Cancer Diagnostic Market Size (2018-2029)
2 Pancreatic Cancer Diagnostic Market by Type
2.1 Introduction
2.1.1 Imaging
2.1.2 Tumor Biomarker
2.1.3 Biopsy
2.1.4 Others
2.2 Global Pancreatic Cancer Diagnostic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pancreatic Cancer Diagnostic Historic Market Size by Type (2018-2023)
2.2.2 Global Pancreatic Cancer Diagnostic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pancreatic Cancer Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pancreatic Cancer Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pancreatic Cancer Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pancreatic Cancer Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pancreatic Cancer Diagnostic Revenue Breakdown by Type (2018-2029)
3 Pancreatic Cancer Diagnostic Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Pancreatic Cancer Diagnostic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pancreatic Cancer Diagnostic Historic Market Size by Application (2018-2023)
3.2.2 Global Pancreatic Cancer Diagnostic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pancreatic Cancer Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pancreatic Cancer Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pancreatic Cancer Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pancreatic Cancer Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pancreatic Cancer Diagnostic Revenue Breakdown by Application (2018-2029)
4 Pancreatic Cancer Diagnostic Competition Analysis by Players
4.1 Global Pancreatic Cancer Diagnostic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pancreatic Cancer Diagnostic as of 2022)
4.3 Date of Key Players Enter into Pancreatic Cancer Diagnostic Market
4.4 Global Top Players Pancreatic Cancer Diagnostic Headquarters and Area Served
4.5 Key Players Pancreatic Cancer Diagnostic Product Solution and Service
4.6 Competitive Status
4.6.1 Pancreatic Cancer Diagnostic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Siemens
5.1.1 Siemens Profile
5.1.2 Siemens Main Business
5.1.3 Siemens Pancreatic Cancer Diagnostic Products, Services and Solutions
5.1.4 Siemens Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.1.5 Siemens Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Pancreatic Cancer Diagnostic Products, Services and Solutions
5.2.4 GE Healthcare Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Pancreatic Cancer Diagnostic Products, Services and Solutions
5.3.4 Roche Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.3.5 Philips Healthcare Recent Developments
5.4 Philips Healthcare
5.4.1 Philips Healthcare Profile
5.4.2 Philips Healthcare Main Business
5.4.3 Philips Healthcare Pancreatic Cancer Diagnostic Products, Services and Solutions
5.4.4 Philips Healthcare Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.4.5 Philips Healthcare Recent Developments
5.5 Danaher
5.5.1 Danaher Profile
5.5.2 Danaher Main Business
5.5.3 Danaher Pancreatic Cancer Diagnostic Products, Services and Solutions
5.5.4 Danaher Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.5.5 Danaher Recent Developments
5.6 Canon Medical Systems
5.6.1 Canon Medical Systems Profile
5.6.2 Canon Medical Systems Main Business
5.6.3 Canon Medical Systems Pancreatic Cancer Diagnostic Products, Services and Solutions
5.6.4 Canon Medical Systems Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.6.5 Canon Medical Systems Recent Developments
5.7 Abbott
5.7.1 Abbott Profile
5.7.2 Abbott Main Business
5.7.3 Abbott Pancreatic Cancer Diagnostic Products, Services and Solutions
5.7.4 Abbott Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.7.5 Abbott Recent Developments
5.8 Hitachi Medical
5.8.1 Hitachi Medical Profile
5.8.2 Hitachi Medical Main Business
5.8.3 Hitachi Medical Pancreatic Cancer Diagnostic Products, Services and Solutions
5.8.4 Hitachi Medical Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.8.5 Hitachi Medical Recent Developments
5.9 Qiagen
5.9.1 Qiagen Profile
5.9.2 Qiagen Main Business
5.9.3 Qiagen Pancreatic Cancer Diagnostic Products, Services and Solutions
5.9.4 Qiagen Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.9.5 Qiagen Recent Developments
5.10 Myriad Genetics
5.10.1 Myriad Genetics Profile
5.10.2 Myriad Genetics Main Business
5.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Products, Services and Solutions
5.10.4 Myriad Genetics Pancreatic Cancer Diagnostic Revenue (US$ Million) & (2018-2023)
5.10.5 Myriad Genetics Recent Developments
6 North America
6.1 North America Pancreatic Cancer Diagnostic Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Pancreatic Cancer Diagnostic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pancreatic Cancer Diagnostic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pancreatic Cancer Diagnostic Market Dynamics
11.1 Pancreatic Cancer Diagnostic Industry Trends
11.2 Pancreatic Cancer Diagnostic Market Drivers
11.3 Pancreatic Cancer Diagnostic Market Challenges
11.4 Pancreatic Cancer Diagnostic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
